Dearborn Partners Llc
Source: SEC Form 13F · as of Mar 2026Dearborn Partners Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $110.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$110.4M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 128,402 | $27.9M |
| ABTABBOTT LABORATORIES | 217,223 | $22.3M |
| JNJJOHNSON & JOHNSON | 79,864 | $19.5M |
| ZTSZoetis Inc. | 106,920 | $12.6M |
| GILDGILEAD SCIENCES, INC. | 69,875 | $9.7M |
| NVSNovartis AG | 35,208 | $5.4M |
| MRKMerck & Co., Inc. | 35,043 | $4.2M |
| LLYELI LILLY & Co | 4,511 | $4.1M |
| PFEPFIZER INC | 51,083 | $1.4M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 21,392 | $1.2M |
| AMGNAMGEN INC | 1,964 | $691K |
| ELVElevance Health Inc. | 1,208 | $354K |
| PMPhilip Morris International Inc | 2,000 | $331K |
| BMYBRISTOL MYERS SQUIBB CO | 4,748 | $288K |
| NTLAIntellia Therapeutics, Inc. | 14,994 | $192K |
| IGCIGC Pharma, Inc. | 59,401 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.